1. Zang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse ob gene and its human homologue. Nature. 1994. 37:425–432.
2. Campfield L, Smith M, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995. 269:546–548.
3. Pellymounter M, Cullen M, Baker M. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995. 269:540–543.
4. Bray GA, York DA. Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab. 1997. 82:2771–2776.
5. Considine RV, Caro JF. Leptin: genes, concepts and clinical perspective. Horm Res. 1996. 46:249–256.
6. Tuominen JA, Ebeling P, Stenman UH, Stephens TW, Koivisto VA. Leptin synthesis is resistant to acute effects of insulin in IDDM patients. J Clin Endocrinol Metab. 1997. 82:381–382.
7. Segal K, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 1996. 45:987–991.
8. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia. 1978. 14:141–148.
9. Pollock ML, Laughridge EE, Coleman B, Linnerud AC, Jackson A. Prediction of body density in young and middle-aged women. J Appl Physiol. 1975. 38:745–749.
10. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr Jan. 2004. 91:161–168.
11. Kim HK, Matsuura Y, Tanaka K, Inagaki A, Nakadomo F. The equation relating body density to percent body fat in boys and girls. Ann Physiol Anthropol. 1993. 12:71–77.
12. Considine RV, Sinha MK, Heiman ML, McKee LJ, Bauer TL, Caro JF. Serum leptin concentrations in normal weight and obese humans. N Eng J Med. 1996. 334:292–295.
15. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab. 1997. 82:654–657.
18. Comizio R, Pietrobelli A, Tan YX, Wang Z, Withers RT, Heymsfield SB, Boozer CN. Total body lipid and triglyceride response to energy deficit: relevance to body composition models. Am Physiol. 1998. 274(5 Pt 1):E860–E866.
19. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005. 365:1333–1346.
20. Schrauwen P, Hesselink MK. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes. 2004. 53:1412–1417.
21. Kennedy A, Getts TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Cli Endocrinol Metab. 1997. 82:1293–1300.
22. Tufano A, Marzo P, Enrini R, Morricone L, Caviezel F, Ambrosi B. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. Endocrinol Invest. 2004. 27:648–653.
23. Huang KC, Lin RC, Kormas N, Lee LT, Chen CY, Gill TP, Caterson ID. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents. Int J Obes Relat Metab Disord. 2004. 28:470–475.
24. Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. Leptin and other components of the Metabolic Syndrome in Mauritius-a factor analysis. Int J Obes Relat Metab Disord. 2001. 25:126–131.
25. Soderberg S, Ahren B, Eliasson M, Dinesen B, Olsson T. The association between leptin and proinsulin is lost with central obesity. J Intern Med. 2002. 252:140–148.